CoreCap Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $737 | Hold |
44
| – | – | ﹤0.01% | 2452 |
|
|
2025
Q1 | $676 | Hold |
44
| – | – | ﹤0.01% | 2609 |
|
|
2024
Q4 | $970 | Sell |
44
-1,000
| -96% | -$22K | ﹤0.01% | 2380 |
|
|
2024
Q3 | $18.8K | Buy |
+1,044
| New | +$18.8K | ﹤0.01% | 1588 |
|
|
2024
Q2 | – | Sell |
-1,044
| Closed | -$14.7K | – | 2490 |
|
|
2024
Q1 | $14.7K | Buy |
+1,044
| New | +$14.7K | ﹤0.01% | 1605 |
|
|
2022
Q4 | $1.82K | Buy |
+200
| New | +$1.82K | ﹤0.01% | 1953 |
|
|
2022
Q1 | – | Sell |
-71
| Closed | -$1K | – | 1927 |
|
|
2021
Q4 | $1K | Buy |
+71
| New | +$1K | ﹤0.01% | 2251 |
|